Skip to content
Anticancer Bioscience
  • Home
  • About Us
    • Our Heritage
    • Operations
    • Team
    • Investors
  • Science
    • Discovery Platforms
    • Pipeline
    • Publications
  • Partners
    • Academic Partners
    • Commercial Partners
  • News & Events
    • Press Releases
    • Events
    • In the News
  • Careers
  • Contact Us
Anticancer Bioscience

Press Releases

September 9, 2021

Anticancer Bioscience Announces its First Granted US Patent for Synthetic Lethal Approach to Identifying Novel Cancer Treatments

Read More
July 14, 2021

Anticancer Bioscience Appoints Leader in Oncology Drug Development, Dr. Hong Liu, as US-based VP of Clinical Development

Read More
May 11, 2021

Anticancer Bioscience Announces Preclinical Data of Lead Compounds Against Novel Myc Synthetic Lethal Target in Cancer

Read More
February 8, 2021

Anticancer Bioscience Announces CNY63m (~USD10m) Financing to Advance its Synthetic Lethal Platform and Pre-clinical Oncology Pipeline

Read More
January 12, 2021

Anticancer Bioscience Presenting at Biotech Showcase™ Digital 2021 Showcasing its Synthetic Lethal Precision Oncology Pipeline for the First Time

Read More
  • Chengdu, China
  • St Andrews, UK
  • San Francisco, USA
  • Sydney, Australia
  • Hyderabad, India
  • Linkedin
  • Twitter
  • Anticancer Bioscience © 2021
  • info@anticancerbio.com

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.

  • Home
  • About Us
    • Our Heritage
    • Operations
    • Team
    • Investors
  • Science
    • Discovery Platforms
    • Pipeline
    • Publications
  • Partners
    • Academic Partners
    • Commercial Partners
  • News & Events
    • Press Releases
    • Events
    • In the News
  • Careers
  • Contact Us